[HTML][HTML] Immunosenescence: a key player in cancer development
J Lian, Y Yue, W Yu, Y Zhang - Journal of hematology & oncology, 2020 - Springer
Immunosenescence is a process of immune dysfunction that occurs with age and includes
remodeling of lymphoid organs, leading to changes in the immune function of the elderly …
remodeling of lymphoid organs, leading to changes in the immune function of the elderly …
[HTML][HTML] State of the art in combination immuno/radiotherapy for brain metastases: systematic review and meta-analysis
Objectives: Common origins for brain metastases (BMs) are melanoma, lung, breast, and
renal cell cancers. BMs account for a large share of morbidity and mortality caused by these …
renal cell cancers. BMs account for a large share of morbidity and mortality caused by these …
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis
E Lee, X Chen, MC LeCompte, LR Kleinberg… - … of Neurosurgery: Spine, 2023 - thejns.org
OBJECTIVE Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has
revolutionized the treatment of patients with many tumor histologies. Simultaneously …
revolutionized the treatment of patients with many tumor histologies. Simultaneously …
Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review
AG Gouveia, DCW Chan, PJ Hoskin, GN Marta… - Radiotherapy and …, 2021 - Elsevier
In patients with bone metastases (BM), radiotherapy (RT) is used to alleviate symptoms,
reduce the risk of fracture, and improve quality of life (QoL). However, with the emergence of …
reduce the risk of fracture, and improve quality of life (QoL). However, with the emergence of …
[HTML][HTML] Efficacy and safety of CyberKnife radiosurgery in elderly patients with brain metastases: a retrospective clinical evaluation
G Acker, SM Hashemi, J Fuellhase, A Kluge, A Conti… - Radiation …, 2020 - Springer
Background Stereotactic radiosurgery (SRS) has been increasingly applied for up to 10
brain metastases instead of whole brain radiation therapy (WBRT) to achieve local tumor …
brain metastases instead of whole brain radiation therapy (WBRT) to achieve local tumor …
Radiotherapy for non-Hodgkin lymphomas
BS Imber, J Yahalom - The Cancer Journal, 2020 - journals.lww.com
Radiotherapy (RT) plays a diverse and essential role in the contemporary management of
non-Hodgkin lymphoma (NHL) and remains the single most powerful monotherapeutic …
non-Hodgkin lymphoma (NHL) and remains the single most powerful monotherapeutic …
Targeting programmed cell death protein 1 (PD-1) for treatment of non-small-cell lung carcinoma (NSCLC); the recent advances
T Dehghani, A Shahrjerdi, MS Kahrizi… - … -Research and Practice, 2023 - Elsevier
The immune system uses various immune checkpoint axes to adjust responses, support
homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung …
homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung …
[HTML][HTML] Theranostic nanoparticles enhance the response of glioblastomas to radiation
Despite considerable progress with our understanding of glioblastoma multiforme (GBM)
and the precise delivery of radiotherapy, the prognosis for GBM patients is still unfavorable …
and the precise delivery of radiotherapy, the prognosis for GBM patients is still unfavorable …
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity
F Cuccia, R Mazzola, E Pastorello, V Figlia… - Clinical & Experimental …, 2021 - Springer
The constantly increasing life expectancy is raising the issue of treating oncological older
patients, who were traditionally candidates to best supportive care or palliative treatments …
patients, who were traditionally candidates to best supportive care or palliative treatments …
[PDF][PDF] Non-stereotactic radiotherapy in older cancer patients
S Parisi, S Lillo, A Cacciola, G Ferini, V Valenti, A Viola… - Heliyon, 2022 - cell.com
Old or very old oncological patients represent a heterogeneous and frail population due to
concomitant comorbidities. Whether radiotherapy alone or in combination with novel cancer …
concomitant comorbidities. Whether radiotherapy alone or in combination with novel cancer …